Hand-foot-skin reaction of grade ≥ 2 within sixty days as the optimal clinical marker best help predict survival in sorafenib therapy for HCC.
第一作者:
Enxin,Wang
第一单位:
Department of Liver Disease and Digestive Interventional Radiology, National Clinical Research Center for Digestive Diseases and Xijing Hospital of Digestive Diseases, Fourth Military Medical University, 15 West Changle Road, Xi'an, 710032, China.
作者:
主题词
成年人(Adult);抗肿瘤药(Antineoplastic Agents);癌, 肝细胞(Carcinoma, Hepatocellular);女(雌)性(Female);随访研究(Follow-Up Studies);人类(Humans);肝肿瘤(Liver Neoplasms);男(雄)性(Male);中年人(Middle Aged);预后(Prognosis);回顾性研究(Retrospective Studies);存活率(Survival Rate)
DOI
10.1007/s10637-018-0640-7
PMID
30019101
发布时间
2022-08-01
- 浏览9

Investigational new drugs
401-414页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文